Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Investing Activities (2020 - 2025)

Agilon Health (AGL) has disclosed Cash from Investing Activities for 6 consecutive years, with $22.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 4.6% year-over-year to $22.6 million, compared with a TTM value of $88.6 million through Dec 2025, down 36.66%, and an annual FY2025 reading of $88.6 million, down 36.66% over the prior year.
  • Cash from Investing Activities was $22.6 million for Q4 2025 at Agilon Health, up from $18.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $70.5 million in Q2 2025 and bottomed at -$296.6 million in Q2 2022.
  • Average Cash from Investing Activities over 5 years is -$17.5 million, with a median of -$5.3 million recorded in 2021.
  • The sharpest move saw Cash from Investing Activities crashed 2944.51% in 2021, then surged 1174.58% in 2024.
  • Year by year, Cash from Investing Activities stood at -$2.6 million in 2021, then plummeted by 206.19% to -$8.0 million in 2022, then skyrocketed by 72.36% to -$2.2 million in 2023, then soared by 1174.58% to $23.7 million in 2024, then fell by 4.6% to $22.6 million in 2025.
  • Business Quant data shows Cash from Investing Activities for AGL at $22.6 million in Q4 2025, $18.7 million in Q3 2025, and $70.5 million in Q2 2025.